EcoDrugPlus

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSMPUG00000017162
Gene Symbol: GHSR
3 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSMPUG00000005699
Gene Symbol: GUCY1A1
2 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSMPUG00000006254
Gene Symbol: GUCY1A2
2 Cross references
201 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSMPUG00000005708
Gene Symbol: GUCY1B1
2 Cross references
209 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class B Member 1

Ensembl ID : ENSMPUG00000012592
Gene Symbol: HSP90AB1
2 Cross references
205 Possible Orthologues:

High Mobility Group Box 1

Ensembl ID : ENSMPUG00000004579
Gene Symbol: HMGB1
2 Cross references
229 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSMPUG00000020115
Gene Symbol: HRH1
2 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSMPUG00000012609
Gene Symbol: HRH2
2 Cross references
249 Possible Orthologues:

Histamine Receptor H3

Ensembl ID : ENSMPUG00000007765
Gene Symbol: HRH3
2 Cross references
117 Possible Orthologues:

Histamine Receptor H4

Ensembl ID : ENSMPUG00000006279
Gene Symbol: HRH4
2 Cross references
103 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSMPUG00000015231
Gene Symbol: HDAC1
2 Cross references
278 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSMPUG00000002331
Gene Symbol: HDAC10
2 Cross references
181 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).